Interleukin-12 in Treating Patients With Multiple Myeloma
This study has been completed.
Eastern Cooperative Oncology Group
Information provided by:
National Cancer Institute (NCI)
First received: November 1, 1999
Last updated: June 20, 2013
Last verified: March 2009
No Study Results Posted on ClinicalTrials.gov for this Study
|Study Status:||This study has been completed.|
|Study Completion Date:||September 2006|
|Estimated Primary Completion Date:||No date given|
Lacy MQ, Jacobus S, Blood EA, Kay NE, Rajkumar SV, Greipp PR. Phase II study of interleukin-12 for treatment of plateau phase multiple myeloma (E1A96): A trial of the Eastern Cooperative Oncology Group. Leuk Res. 2009 Feb 23; [Epub ahead of print]
Lacy MQ, Blood E, Kay N, et al.: Interleukin-12 treatment for plateau phase multiple myeloma: an Eastern Cooperative Oncology Group (ECOG) phase II trial (E1A96). [Abstract] Blood 100 (11 pt 1): A-1549, 2002.